| 注册
首页|期刊导航|中国药物评价|基于特征图谱结合化学模式识别的脾氨肽口服冻干粉质量评价

基于特征图谱结合化学模式识别的脾氨肽口服冻干粉质量评价

刘雨浓 李悦忱 崔韶婧 田洁 邹翩

中国药物评价2025,Vol.42Issue(3):172-176,5.
中国药物评价2025,Vol.42Issue(3):172-176,5.

基于特征图谱结合化学模式识别的脾氨肽口服冻干粉质量评价

Quality Evaluation of Spleen Aminopeptide Oral Lyophilized Powder Based on Characteristic Chromatogram Combined with Chemical Pattern Recognition

刘雨浓 1李悦忱 1崔韶婧 1田洁 1邹翩1

作者信息

  • 1. 大连市检验检测认证技术服务中心 大连市药品检验检测院,辽宁大连 116021
  • 折叠

摘要

Abstract

Objective:To establish an analytical method for the characteristic chromatogram of spleen aminopeptide oral lyophilized powder and evaluate its quality using chemical pattern recognition,providing a basis for its scientific identification and quality control.Methods:The characteristic chromatogram was developed using liquid chromatography(HPLC),and 22 batches of samples(S1-S22)were classified using cluster analysis and principal component analysis from chemical pattern recognition methods.Additionally,orthogo-nal partial least squares-discriminant analysis was employed to identify key components distinguishing spleen aminopeptide oral lyophilized powder.Results:The characteristic chromatogram was established based on 22 batches of samples,identifying 14 common peaks and confirming four components:inosine,tyrosine,tryptophan,and thymosin β4.The samples were divided into two categories based on clus-ter analysis and principal component analysis.Orthogonal partial least squares discriminant analysis further screened seven quality-differ-entiating marker components,including thymosin β4.Conclusion:The characteristic chromatogram of spleen aminopeptide oral lyophi-lized powder established in this study is accurate,stable,and reliable,providing a reference for controlling and evaluating its quality.

关键词

脾氨肽口服冻干粉/特征图谱/化学模式识别/质量评价

Key words

Spleen aminopeptide oral lyophilized powder/Characteristic chromatogram/Chemical pattern recognition/Quality evaluation

分类

医药卫生

引用本文复制引用

刘雨浓,李悦忱,崔韶婧,田洁,邹翩..基于特征图谱结合化学模式识别的脾氨肽口服冻干粉质量评价[J].中国药物评价,2025,42(3):172-176,5.

基金项目

大连市科技人才创新支持项目-青年科技之星(2023RQ024) (2023RQ024)

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文